Exploring Substituted Tetrazoloquinazoline: Biological Activities, Molecular Docking Analysis, and Anti-Breast Cancer MCF7/HER2 Effects

Breast cancer is a condition where breast tissue cells grow uncontrollably. Various natural and synthesized compounds, such as quinazoline, have been studied for their potential as anticancer agents. Quinazoline derivatives have shown diverse bioactivities, including antimalarial, antifungal, antimi...

Full description

Saved in:
Bibliographic Details
Main Authors: Neni Frimayanti, Ihsan Ikhtiarudin, Rahma Dona, Rahul Oktarizal, Aprilia Cindy Nurfatimah
Format: Article
Language:English
Published: Wiley 2024-01-01
Series:Advances in Pharmacological and Pharmaceutical Sciences
Online Access:http://dx.doi.org/10.1155/2024/6952142
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832544188285059072
author Neni Frimayanti
Ihsan Ikhtiarudin
Rahma Dona
Rahul Oktarizal
Aprilia Cindy Nurfatimah
author_facet Neni Frimayanti
Ihsan Ikhtiarudin
Rahma Dona
Rahul Oktarizal
Aprilia Cindy Nurfatimah
author_sort Neni Frimayanti
collection DOAJ
description Breast cancer is a condition where breast tissue cells grow uncontrollably. Various natural and synthesized compounds, such as quinazoline, have been studied for their potential as anticancer agents. Quinazoline derivatives have shown diverse bioactivities, including antimalarial, antifungal, antimicrobial, and anticancer properties. This research aims to synthesize substituted tetrazoloquinazoline and evaluate its potential as an anticancer agent using molecular docking studies with the Molecular Operating Environment (MOE) software. Furthermore, molecular dynamic was also performed to analyze the binding stability of this protein-ligand complex. Additionally, the physicochemical and pharmacokinetic properties of quinazoline compounds were assessed using the website https://www.swissadme.ch. The cytotoxic activity of the compounds was evaluated using the MTT assay. The docking results revealed that substituted tetrazoloquinazoline exhibited a significantly different range of binding free energy compared to the positive control. Moreover, the substituted tetrazoloquinazoline compounds comply with Lipinski’s Rule of Five (Ro5), indicating that they are easily absorbable and have good permeability. The cytotoxic activity of the compounds was found to have an IC50 value of >1000 ppm, classifying them as noncytotoxic. It therefore paved the way for the discovery of promising next-generation drugs against breast cancer.
format Article
id doaj-art-375318d93244452dad6552db45e2b352
institution Kabale University
issn 2633-4690
language English
publishDate 2024-01-01
publisher Wiley
record_format Article
series Advances in Pharmacological and Pharmaceutical Sciences
spelling doaj-art-375318d93244452dad6552db45e2b3522025-02-03T10:52:36ZengWileyAdvances in Pharmacological and Pharmaceutical Sciences2633-46902024-01-01202410.1155/2024/6952142Exploring Substituted Tetrazoloquinazoline: Biological Activities, Molecular Docking Analysis, and Anti-Breast Cancer MCF7/HER2 EffectsNeni Frimayanti0Ihsan Ikhtiarudin1Rahma Dona2Rahul Oktarizal3Aprilia Cindy Nurfatimah4Department of PharmacyDepartment of PharmacyDepartment of PharmacyDepartment of PharmacyDepartment of ChemistryBreast cancer is a condition where breast tissue cells grow uncontrollably. Various natural and synthesized compounds, such as quinazoline, have been studied for their potential as anticancer agents. Quinazoline derivatives have shown diverse bioactivities, including antimalarial, antifungal, antimicrobial, and anticancer properties. This research aims to synthesize substituted tetrazoloquinazoline and evaluate its potential as an anticancer agent using molecular docking studies with the Molecular Operating Environment (MOE) software. Furthermore, molecular dynamic was also performed to analyze the binding stability of this protein-ligand complex. Additionally, the physicochemical and pharmacokinetic properties of quinazoline compounds were assessed using the website https://www.swissadme.ch. The cytotoxic activity of the compounds was evaluated using the MTT assay. The docking results revealed that substituted tetrazoloquinazoline exhibited a significantly different range of binding free energy compared to the positive control. Moreover, the substituted tetrazoloquinazoline compounds comply with Lipinski’s Rule of Five (Ro5), indicating that they are easily absorbable and have good permeability. The cytotoxic activity of the compounds was found to have an IC50 value of >1000 ppm, classifying them as noncytotoxic. It therefore paved the way for the discovery of promising next-generation drugs against breast cancer.http://dx.doi.org/10.1155/2024/6952142
spellingShingle Neni Frimayanti
Ihsan Ikhtiarudin
Rahma Dona
Rahul Oktarizal
Aprilia Cindy Nurfatimah
Exploring Substituted Tetrazoloquinazoline: Biological Activities, Molecular Docking Analysis, and Anti-Breast Cancer MCF7/HER2 Effects
Advances in Pharmacological and Pharmaceutical Sciences
title Exploring Substituted Tetrazoloquinazoline: Biological Activities, Molecular Docking Analysis, and Anti-Breast Cancer MCF7/HER2 Effects
title_full Exploring Substituted Tetrazoloquinazoline: Biological Activities, Molecular Docking Analysis, and Anti-Breast Cancer MCF7/HER2 Effects
title_fullStr Exploring Substituted Tetrazoloquinazoline: Biological Activities, Molecular Docking Analysis, and Anti-Breast Cancer MCF7/HER2 Effects
title_full_unstemmed Exploring Substituted Tetrazoloquinazoline: Biological Activities, Molecular Docking Analysis, and Anti-Breast Cancer MCF7/HER2 Effects
title_short Exploring Substituted Tetrazoloquinazoline: Biological Activities, Molecular Docking Analysis, and Anti-Breast Cancer MCF7/HER2 Effects
title_sort exploring substituted tetrazoloquinazoline biological activities molecular docking analysis and anti breast cancer mcf7 her2 effects
url http://dx.doi.org/10.1155/2024/6952142
work_keys_str_mv AT nenifrimayanti exploringsubstitutedtetrazoloquinazolinebiologicalactivitiesmoleculardockinganalysisandantibreastcancermcf7her2effects
AT ihsanikhtiarudin exploringsubstitutedtetrazoloquinazolinebiologicalactivitiesmoleculardockinganalysisandantibreastcancermcf7her2effects
AT rahmadona exploringsubstitutedtetrazoloquinazolinebiologicalactivitiesmoleculardockinganalysisandantibreastcancermcf7her2effects
AT rahuloktarizal exploringsubstitutedtetrazoloquinazolinebiologicalactivitiesmoleculardockinganalysisandantibreastcancermcf7her2effects
AT apriliacindynurfatimah exploringsubstitutedtetrazoloquinazolinebiologicalactivitiesmoleculardockinganalysisandantibreastcancermcf7her2effects